PTGS2 and Alzheimer disease: Moreover, plasma MALAT1, miR-125b, FOXQ1, PTGS2, and CDK5 could distinguish AD patients from controls, while only plasma MALAT1, miR-125b, and PTGS2 could discriminate AD patients from Parkinson’s disease patients [23].